8-Chloroimidazo[1,2-a]pyrazine, 95.0%, 10g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3-cyanophenyl)butanoic acid, 98%, 100mg

[(4R)-2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl]acetic acid, 97.0%, 5g

1-Methyl-1H-1,2,4-triazol-5-amine, 95.0%, 5g

1,6-Bis(acryloyloxy)-2,2,3,3,4,4,5,5-octafluorohexane (stabilized with MEHQ)>90.0%(GC)1g

1-Phenyl-1H-indole>98.0%(N)1g

(2E)-3-(2-chloro-6-fluorophenyl)-1-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl 5-(1-hydroxyethyl)-3-phenylisoxazole-4-carboxylate, 95.0%, 5g

2-(Piperidin-1-yl)ethanol, 95.0%, 100g

Acetato di isopropenile, minimo 98%, per sintesi, 250 ml, confezione in vetro

m-Tolyldiethanolamine>98.0%(T)500g

tert-Butyl ((S)-1-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate, 98%, 1g

5,5-Dimethyl-2-(p-tolyl)-1,3,2-dioxaborinane, 98.0%, 5g